Content Source/Owner:
Drbeen Medical Lectures
40 min
Summary:
The BMJ has a beautifully written article which highlights some of the issues with the current evidence based medicine practices.
They also have a great list of proposals to correct these anomalies. Let’s review.
My additions to the fixed proposed by thebmj:
Forbid high level employees from a large corporation to join regulatory agencies.
Forbid high level employees of a regulatory agency from joining large organizations.
Forbid either of these employees to join startups as board members or PR team. They can join as research workers or other internal facing employees.
Tax big corporations to fund independent organizations that will review, analyze, and certify the trial data. These organizations should be the public’s representation.
Formulate a non-government non-corporate drug review board that should go over the phase IV results of all the newly approved drugs and recommend to stop or continue based on these results.
Non medical hospital management should not be part of the therapy policy maker or enforcers.
Correct the political leaning of the state medical boards.
Fine the media pundits/gurus that represent drugs/therapies without having the credentials to discuss medicine.
On yearly basis make public all communications about drug trials and approvals.
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
—-
URL list from Wednesday, Mar. 30, 2022
The illusion of evidence based medicine | The BMJ
Clinical trials and drug promotion: Selective reporting of study 329 – IOS Press
Narrative review: the promotion of gabapentin: an analysis of internal industry documents – PubMed
Risk of cardiovascular events associated with selective COX-2 inhibitors – PubMed
Pandemrix vaccine: why was the public not told of early warning signs? | The BMJ
The BMJ – Wikipedia
pharma sponsoring cmes in the us after:01-01-2017 – Google Search
New Jersey Finalizes “Gift” Ban of Physicians Working with the Pharmaceutical Industry – Policy & Medicine
Medical Marketing in the United States, 1997-2016 | Health Care Economics, Insurance, Payment | JAMA | JAMA Network
Pharma, medtech spending accounted for 28% of CME funds in 2017 | Healthcare Dive
778_20180712_2017_Data_Report.pdf
902_20210615_2020 Data Report.pdf
Prescription for Conflict: CME Funding from Big Pharma to Big Placebo – Policy & Medicine
~~~
DrBeen: Continuing Medical Education Online | USMLE Prep | CME and CE marketplace | Nurse Practitioner and Physician Assistant Training Programs | Medical Student Training
Want to support this work?:
Buy me a coffee 🙂 https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed
Donate here: https://paypal.me/mobeensyed
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
————-